麻豆直播app

Diabetes: Eye Exam

The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who had an eye exam (retinal) performed.

Date Reviewed: November 4, 2018

Measure Info

MIPS 117 NQF 0055 CMS 117 NQF Endorsed
Measure Type
Process
Measure Steward
National Committee for Quality Assurance
Clinical Topic Area
Diabetes

Care Setting
Outpatient
Data Source
Claims
Electronic Health Records
Paper Medical Records
Registry

ACP supports MIPS measure ID#117 (NQF ID# 0055): 鈥淒iabetes: Eye Exam鈥 because the opportunity for improvement is well documented, developers cite the 2018 clinical recommendations of the American Diabetes Association for the 鈥淪tandards of Medical Care in Diabetes鈥 to form the basis of the measure, the specifications are well defined, and the denominator includes well specified and clinically appropriate exceptions to eligibility for the measure. While we support this measure, we suggest the developers address the following points during the next review to update the measure. First, implementation could promote overuse because some modeling studies support >2 year screening intervals in patients who have an HbA1c of <7% with normal prior eye exams. Second, we note that while poor interoperability across EHRs poses some data collection burden on clinicians who report this measure, the onus should be on the clinician who is managing the diabetes to ensure that patients who are diagnosed with diabetes are screened for diabetic retinal disease. Finally, we suggest that the developers revise the specifications to include all patients over the age of 18 years, as long as the risk of retinopathy is specified for older patients. The current American Geriatrics Society guidelines support biennial screening for all adults, including for patients who are over the age of 75 years who are at risk for retinopathy.